Gamgertamig
Gamgertamig is a humanized IgG4 bispecific antibody targeting TNFRSF17 & CD3E[1].
Product Specifications
CAS Number
3038119-48-8
UNSPSC
12352100
Target
CD3; TNF Receptor
Related Pathways
Apoptosis; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
References & Citations
[1]WHO Drug Information, Vol. 39, No. 2, 2025.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog